Holen Sie sich die Stockscreener-App
1,064.29
2.12%
-23.09
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LLY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$1,087.38
Offen:
$1083.73
24-Stunden-Volumen:
2.57M
Relative Volume:
0.74
Marktkapitalisierung:
$952.56B
Einnahmen:
$59.42B
Nettoeinkommen (Verlust:
$18.41B
KGV:
52.64
EPS:
20.2197
Netto-Cashflow:
$6.44B
1W Leistung:
+2.49%
1M Leistung:
-0.69%
6M Leistung:
+33.22%
1J Leistung:
+38.83%
1-Tages-Spanne:
$1,063.02
$1,084.32
1-Wochen-Bereich:
$1,015.96
$1,095.48
52-Wochen-Spanne:
$623.78
$1,133.95
Lilly Eli Co Stock (LLY) Company Profile
Firmenname
Lilly Eli Co
Sektor
Telefon
(317) 276-2000
Adresse
LILLY CORPORATE CTR, INDIANAPOLIS, IN
Vergleichen Sie LLY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LLY
Lilly Eli Co
|
1,064.29 | 973.23B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
220.14 | 526.41B | 94.19B | 26.80B | 20.46B | 11.05 |
|
ABBV
Abbvie Inc
|
219.26 | 385.48B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
147.14 | 278.22B | 54.45B | 14.42B | 17.15B | 7.333 |
|
NVO
Novo Nordisk Adr
|
62.26 | 276.52B | 46.69B | 15.29B | 9.25B | 3.4329 |
Lilly Eli Co Stock (LLY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-07 | Fortgesetzt | UBS | Buy |
| 2025-12-16 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2025-12-15 | Bestätigt | BofA Securities | Buy |
| 2025-12-15 | Bestätigt | Goldman | Buy |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-11-10 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-10-20 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-10-14 | Hochstufung | Erste Group | Hold → Buy |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-08-27 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2025-08-18 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2025-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-06-05 | Herabstufung | Erste Group | Buy → Hold |
| 2025-04-28 | Herabstufung | HSBC Securities | Buy → Reduce |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-09-13 | Fortgesetzt | Citigroup | Buy |
| 2024-08-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-02-21 | Herabstufung | DZ Bank | Buy → Hold |
| 2024-02-16 | Bestätigt | Morgan Stanley | Overweight |
| 2023-12-21 | Herabstufung | Daiwa Securities | Buy → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-10-20 | Fortgesetzt | UBS | Buy |
| 2023-08-09 | Hochstufung | Jefferies | Hold → Buy |
| 2023-07-26 | Bestätigt | Citigroup | Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Buy |
| 2023-05-24 | Bestätigt | BofA Securities | Buy |
| 2023-05-24 | Bestätigt | UBS | Buy |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-03-06 | Eingeleitet | Jefferies | Hold |
| 2023-02-15 | Herabstufung | Societe Generale | Hold → Sell |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-09-22 | Hochstufung | UBS | Neutral → Buy |
| 2022-05-23 | Eingeleitet | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-03-10 | Eingeleitet | Daiwa Securities | Outperform |
| 2022-01-21 | Hochstufung | DZ Bank | Hold → Buy |
| 2022-01-03 | Bestätigt | Bernstein | Mkt Perform |
| 2021-12-17 | Eingeleitet | Goldman | Neutral |
| 2021-12-16 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-12-16 | Bestätigt | BofA Securities | Buy |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-10-11 | Hochstufung | Berenberg | Hold → Buy |
| 2021-09-29 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-08-05 | Hochstufung | DZ Bank | Hold → Buy |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-06-24 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2021-01-19 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-11-10 | Fortgesetzt | Bernstein | Mkt Perform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-09-03 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-04-21 | Herabstufung | UBS | Buy → Neutral |
| 2020-04-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-06 | Eingeleitet | Mizuho | Neutral |
| 2019-12-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Buy |
| 2019-04-24 | Hochstufung | Edward Jones | Hold → Buy |
| 2019-04-11 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-03-12 | Eingeleitet | JP Morgan | Overweight |
| 2019-01-23 | Eingeleitet | UBS | Buy |
| 2018-11-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-10-31 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2018-10-09 | Eingeleitet | Guggenheim | Buy |
| 2018-10-01 | Bestätigt | SunTrust | Buy |
| 2018-09-26 | Fortgesetzt | JP Morgan | Overweight |
Alle ansehen
Lilly Eli Co Aktie (LLY) Neueste Nachrichten
Whittier Trust Co. of Nevada Inc. Buys 2,524 Shares of Eli Lilly and Company $LLY - MarketBeat
Whittier Trust Co. Purchases 6,224 Shares of Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company $LLY Shares Acquired by Kanawha Capital Management LLC - MarketBeat
First Citizens Bank & Trust Co. Purchases 9,121 Shares of Eli Lilly and Company $LLY - MarketBeat
Eli Lilly Shares Face Pressure as Key Drug Approval Timeline Shifts - AD HOC NEWS
3 Growth Stocks to Invest $1,000 in Right Now - The Motley Fool
Should You Dump Eli Lilly's Shares After This Setback? - The Motley Fool
The Truth About Eli Lilly (NYSEreplacing with LPLA): Why Everyone Is Suddenly Watching This Stock - AD HOC NEWS
Eli Lilly stock slips as obesity-drug headlines pile up ahead of next week - TechStock²
Guggenheim Reduces PT on Eli Lilly and Company (LLY) to $1,161, Reiterates 'Buy' Rating - Finviz
Eli Lilly and Company $LLY Shares Sold by Symphony Financial Ltd. Co. - MarketBeat
Mn Services Vermogensbeheer B.V. Has $233.24 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Dash Acquisitions Inc. Raises Stake in Eli Lilly and Company $LLY - MarketBeat
Jennison Associates LLC Has $3.20 Billion Holdings in Eli Lilly and Company $LLY - MarketBeat
BAM Wealth Management LLC Invests $1.09 Million in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly Shares: Market Experts Maintain Bullish Outlook Despite Recent Weakness - AD HOC NEWS
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead? - Finviz
Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q4 Earnings - The Globe and Mail
How the CEOs of AI leader Nvidia and drug giant Lilly drove a groundbreaking collaboration - The Business Journals
Bernstein Sees Eli Lilly Stock (LLY) Hitting $1,300 Per Share - TipRanks
Lockheed Martin Investment Management Co. Sells 27,400 Shares of Eli Lilly and Company $LLY - MarketBeat
Vantage Investment Partners LLC Has $39.54 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Spear Holdings RSC Ltd Reduces Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
ELI LILLY & CO (NYSE:LLY) Offers a Durable Dividend with Strong Growth and Financial Health - Chartmill
What obesity drugmakers see next in the market: More pills, easier access and drug combinations - CNBC
Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 - Finviz
Cipla Explores Semaglutide Generics Market Entry, Partners with Eli Lilly for Mounjaro Launch - scanx.trade
Eli Lilly and Company $LLY Shares Purchased by Envestnet Portfolio Solutions Inc. - MarketBeat
iA Global Asset Management Inc. Raises Stake in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly’s Strategic Pipeline Developments Amid Market Volatility - AD HOC NEWS
Llamas Are Big Pharma’s Secret Weapon to Find New Drugs - Bloomberg
Eli Lilly’s Strategic Expansion: Pipeline Progress and Financial Outlook - AD HOC NEWS
Nvidia CEO to Lilly CEO: You Were Running Around the Forest … - Dealbreaker
Eli Lilly (LLY) Shines Amid Healthcare Sector's Underperformance - GuruFocus
Eli Lilly and Co's Options Frenzy: What You Need to Know - Benzinga
Vest Financial LLC Buys 2,178 Shares of Eli Lilly and Company $LLY - MarketBeat
Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research & Development from AbbVie, Amgen and Eli Lilly at 2026 Global Partnering & Investor Conference - BioSpace
Bey Douglas LLC Reduces Holdings in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly’s Oncology Ambitions Gain Momentum with Key FDA Designation - AD HOC NEWS
Nvidia CEO to Lilly CEO: You were running around the forest … - MedCity News
Eli Lilly and Company (NYSE:LLY) Stock Price Up 3.6%Time to Buy? - MarketBeat
Vital Signs: Unwrapping J&J's $100 billion ambition - FirstWord Pharma
Why Eli Lilly (LLY) Stock Is Up Today - Finviz
Beyond the Silicon: NVIDIA and Eli Lilly Launch $1 Billion ‘Physical AI’ Lab to Rewrite the Rules of Medicine - FinancialContent
Eli Lilly’s Oncology Pipeline Gains Momentum with Key Regulatory Designation - AD HOC NEWS
Stock Yards Bank & Trust Co. Acquires 1,197 Shares of Eli Lilly and Company $LLY - MarketBeat
Eli Lilly: Buy Ahead Of Its Earnings Day (Preview) (NYSE:LLY) - Seeking Alpha
First-movers respond to biopharma herding into hot targets - Endpoints News
Rakuten Investment Management Inc. Makes New Investment in Eli Lilly and Company $LLY - MarketBeat
Migdal Insurance & Financial Holdings Ltd. Has $137.37 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Joel Isaacson & Co. LLC Acquires 3,976 Shares of Eli Lilly and Company $LLY - MarketBeat
Finanzdaten der Lilly Eli Co-Aktie (LLY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
0.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):